Angels for Change Founder and Chief Change Maker testifies before Congress
“Examining the Root Causes of Drug Shortages: Challenges in Pharmaceutical Drug Supply Chains”. Watch Laura Bray’s, full congressional testimony here.
Our Purpose in Action
“Angels for Change is the Nation’s only Non-profit Patient Advocacy Organization with a mission to End Drug Shortages. ”
The Drug Shorage Crisis
Every day in the US there are patients fighting for their lives, doctors trying to save them, and no way to find life-saving medicines. The drug shortage crisis in the United States is diverse in causality and complex in responsibility.
According to the FDA, drug shortages are among the greatest challenges health care providers and patients face. Drug shortages exist because of a “broken marketplace” that does not respond to the usual forces of supply and demand. When shortages exist, they persist, resulting in patients, doctors, and pharmacists looking for drugs that come late, or not at all.
Angels for Change believes fixing the national drug shortage crisis will require multi-stakeholder collaboration, patient-centric design, and rebuilding the supply chain to ensure patient access for all.
90%
OF MEDICAL ONCOLOGISTS
Report drug shortages have had a negative impact on patient outcome in Angels for Change’s “Assessing the ’Patient Harm’ Caused by Drug Shortages.”
323
NUMBER OF
DRUG SHORTAGES
The highest number recorded in history, ASHP Drug Shortages Survey Report, Q1 2024.
56%
OF HOSPITALS
Reported they had changed patient care or delayed therapy because of drug shortages. (Reported in the FDA’s, “Drug Shortages: Root Causes and Potential Solutions”).
Our Partners
Angels for Change partners with local, regional and national organizations who feel passionate about patient advocacy.
“We founded Angels for Change after my own daughter’s life-saving drug shortage while fighting leukemia. The feeling of hopelessness when she asked me, ‘Am I going die without my medicine?’ is what drives our efforts everyday. We must fix the supply chain for today’s therapies and tomorrow’s cures.”
